Pfizer will not apply for a licence for sildenafil for women

  title={Pfizer will not apply for a licence for sildenafil for women},
  author={Susan Mayor},
  journal={BMJ : British Medical Journal},
  • S. Mayor
  • Published 4 March 2004
  • Psychology, Medicine
  • BMJ : British Medical Journal
Pfizer, the company that developed the phosphodiesterase inhibitor sildenafil (Viagra), reported last week that efficacy results in women with what has been termed female sexual arousal disorder had been inconclusive and would not support filing for regulatory approval to use the drug in this indication. In a statement, Pfizer said that several large scale, placebo controlled studies including about 3000 women with female sexual arousal disorder showed inconclusive results on the efficacy of… 
Hypoactive sexual desire disorder
  • S. Davison
  • Medicine, Psychology
    Current opinion in obstetrics & gynecology
  • 2012
Hypoactive sexual desire disorder (HSDD) is the most prevalent female sexual dysfunction, with estimates of prevalence approximating 10%.
Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14.
Exploration of therapeutic targets for sexual dysfunctions: lessons learned from the failed stories
By learning from failures, a drug may not only be kept alive, but also better therapeutic strategies and design of new drugs may be developed.
The medicalisation of sex: a barrier to intercourse?
This century, young as it is, has witnessed dramatic change in the world of sexology and, in particular, the shift from psychological to pharmacological treatments for sexual problems. This shift,
Women’s sexual desire: challenging narratives of “Dysfunction”
Abstract. Recent changes in the classification of female sexual dysfunction in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the US Food and Drug
Treating desires not diseases: a pill for every ill and an ill for every pill?
Female sexual dysfunction in postmenopausal women
This review discusses female sexual dysfunctions related to the menopausal transition in terms of diagnosis, classification, prevalence, associated risk factors and available treatment options.
A systematic review of experimental and clinical studies of sildenafil citrate for intrauterine growth restriction and pre-term labour
There is still limited information about the efficacy of sildenafil for the treatment of IUGR and premature delivery, however, studies in experimental animal models and two human case reports have reported no deleterious effects on the mother or offspring.
El secreto mejor guardado: la sexualidad de las mujeres mayores
This article focuses on women’s sexuality during the ageing process. It reviews the main epistemological tendencies which claim to explain the features of sexuality in old age as well as any changes